An estimated 3,000 patients will take part in the Stryker metal hip replacement lawsuit settlement announced at the beginning of November, according to attorneys familiar with the case. All of the patients received either a Stryker Rejuvenate or Stryker ABG II hip implant and underwent revision surgery to correct complications related to the device.
The Stryker settlement will involve a base pay of $300,000 per patient, as well as additional compensation to patients who suffered from complications during revision surgery. Stryker estimates its losses from the settlement to range from $1.42 to $2.29 billion.
Stryker issued an ABG II and Rejuvenate recall in 2012 after studies indicated the implants were failing at a much higher rate than expected. Patients have complained of several severe Stryker hip implant side effects, including limited mobility, tissue damage, swelling and toxic levels of cobalt and chromium in the blood stream.